11-130121762-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001142276.2(APLP2):āc.665A>Gā(p.Glu222Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000744 in 1,331,134 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001142276.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APLP2 | NM_001142276.2 | c.665A>G | p.Glu222Gly | missense_variant | 5/17 | ENST00000338167.10 | NP_001135748.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APLP2 | ENST00000338167.10 | c.665A>G | p.Glu222Gly | missense_variant | 5/17 | 1 | NM_001142276.2 | ENSP00000345444 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000418 AC: 5AN: 119726Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251166Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135778
GnomAD4 exome AF: 0.0000776 AC: 94AN: 1211338Hom.: 0 Cov.: 30 AF XY: 0.0000942 AC XY: 57AN XY: 604886
GnomAD4 genome AF: 0.0000417 AC: 5AN: 119796Hom.: 0 Cov.: 31 AF XY: 0.0000508 AC XY: 3AN XY: 59028
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2021 | The c.665A>G (p.E222G) alteration is located in exon 5 (coding exon 5) of the APLP2 gene. This alteration results from a A to G substitution at nucleotide position 665, causing the glutamic acid (E) at amino acid position 222 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at